Interact to see
Advertisement
Advertisement
FSEDX vs PYELX
FSEDX vs PYELX Comparison
Open Charts FSEDX vs PYELX
Fidelity Series Em Mk Dbt Lcl Ccy
Price$9.46
Change+$0.02 (+0.21%)
VolumeN/A
Net Assets439.66M
Payden Emerging Markets Local Bond I
Price$9.69
Change+$0.02 (+0.21%)
VolumeN/A
Net Assets83.51M
FSEDX vs PYELX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
VS
FUNDAMENTALS
Fundamentals
FSEDX has more cash in the bank: 440M vs. PYELX (83.5M). PYELX pays higher dividends than FSEDX: PYELX (6.86) vs FSEDX (4.41). FSEDX was incepted earlier than PYELX: FSEDX (5 years) vs PYELX (14 years). PYELX (1.07) is less costly to investors than FSEDX (0.02). PYELX is a more actively managed with annual turnover of: 61.00 vs. FSEDX (46.00). FSEDX has a lower initial minimum investment than PYELX: FSEDX (0) vs PYELX (5000). FSEDX annual gain was more profitable for investors over the last year : 12.05 vs. PYELX (8.23).
| FSEDX | PYELX | FSEDX / PYELX | |
| Total Expense Ratio | 0.00 | 0.99 | - |
| Annual Report Gross Expense Ratio | 0.02 | 1.07 | 2% |
| Fund Existence | 5 years | 14 years | - |
| Gain YTD | 10.409 | 9.052 | 115% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 5000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 440M | 83.5M | 527% |
| Annual Yield % from dividends | 4.41 | 6.86 | 64% |
| Returns for 1 year | 12.05 | 8.23 | 146% |
| Returns for 3 years | 28.26 | 14.49 | 195% |
| Returns for 5 years | N/A | -5.24 | - |
| Returns for 10 years | N/A | -11.62 | - |
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| FSTRX | 32.51 | 0.05 | +0.17% |
| Federated Hermes MDT Large Cap Value A | |||
| VLCGX | 16.57 | N/A | N/A |
| VALIC Company I Large Capital Growth | |||
| MFMPX | 16.02 | N/A | N/A |
| Morgan Stanley Inst Next Gen Em Mkts A | |||
| LGCSX | 18.39 | N/A | N/A |
| Lord Abbett Global Equity R4 | |||
| VPRAX | 29.41 | N/A | N/A |
| VY® T. Rowe Price Capital Apprec R6 | |||